[Chloroquine cardiotoxicity in long-term lupus therapy in two patients]

Ann Dermatol Venereol. 2009 Jun-Jul;136(6-7):530-5. doi: 10.1016/j.annder.2009.01.016. Epub 2009 Jun 2.
[Article in French]

Abstract

Background: The antimalarial compounds chloroquine and hydroxychloroquine are widely used in the treatment of connective tissue diseases and are usually well tolerated. We report two cases of chloroquine cardiotoxicity.

Patients and methods: Two women (aged 43 and 48 years) were treated for 5 years for lupus. They developed severe conduction disturbances requiring a pacemaker. Plasma chloroquine concentrations were abnormally high in both cases. In one case, a genetic polymorphism modulating the activity of a cytochrome involved in chloroquine metabolism (CYP2C8) was identified.

Discussion: Since 1965, 60 cases of occasionally severe cardiotoxicity have been reported following long-term treatment with chloroquine in most cases, but also with hydroxychloroquine. This toxicity must be detected early and close cardiac assessment is required.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Atrioventricular Block / chemically induced*
  • Atrioventricular Block / therapy
  • Chloroquine / administration & dosage
  • Chloroquine / adverse effects*
  • Electrocardiography
  • Female
  • Humans
  • Lupus Erythematosus, Cutaneous / complications
  • Lupus Erythematosus, Cutaneous / drug therapy
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / drug therapy
  • Middle Aged
  • Pacemaker, Artificial
  • Sjogren's Syndrome / complications
  • Sjogren's Syndrome / drug therapy
  • Ventricular Dysfunction / chemically induced*
  • Ventricular Dysfunction / therapy

Substances

  • Antirheumatic Agents
  • Chloroquine